GSK’s new data underscore important responses with momelotinib for myelofibrosis patients
48-week data from MOMENTUM phase III clinical trial show momelotinib maintained total symptom response
48-week data from MOMENTUM phase III clinical trial show momelotinib maintained total symptom response
GlobalData predicts the average prices of dual chamber pacemakers in both India and China are expected to reduce at an average CAGR of -3.42% from 2022 to 2025.
Anandiben Patel, Governor, Uttar Pradesh will inaugurate the two-day celebrations
The approval follows the positive recommendation from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) in October 2022
The company will set-up a pharmaceuticals formulation manufacturing unit with an investment of Rs. 100 crore in Odisha
These satellite institutes will further strengthen the research, international collaborations and facilitate affordable Ayush services for the larger community.
The use of procalcitonin testing for sepsis management is highest in the US
Proceeds from the transaction will be reinvested towards the growth, innovation and expansion of Healthium’s advanced surgery, orthopaedics, wound care and post-surgical care portfolio
The two-day event focused on the multi-faceted relationship of clinical research stakeholders and looked at bridging the academic and clinical research gap.
Asia’s premier and USA-patented, ANSSI Wellness for spinal decompression was launched in Pune
Subscribe To Our Newsletter & Stay Updated